Free Trial

Daiichi Sankyo (OTCMKTS:DSNKY) Stock Price Up 0.9% - Still a Buy?

Daiichi Sankyo logo with Medical background

Shares of Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY - Get Free Report) were up 0.9% on Tuesday . The stock traded as high as $24.71 and last traded at $23.91. Approximately 368,177 shares changed hands during trading, an increase of 35% from the average daily volume of 272,974 shares. The stock had previously closed at $23.70.

Daiichi Sankyo Price Performance

The company has a 50 day moving average of $23.99 and a two-hundred day moving average of $26.24. The firm has a market cap of $49.54 billion and a P/E ratio of 30.19. The company has a quick ratio of 2.11, a current ratio of 2.77 and a debt-to-equity ratio of 0.06.

Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.30 earnings per share for the quarter. Daiichi Sankyo had a net margin of 13.62% and a return on equity of 14.53%. The company had revenue of $3.40 billion during the quarter. Sell-side analysts expect that Daiichi Sankyo Company, Limited will post 0.73 EPS for the current year.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Further Reading

Should You Invest $1,000 in Daiichi Sankyo Right Now?

Before you consider Daiichi Sankyo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.

While Daiichi Sankyo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines